"No more letting industry help pay for developing medical guidelines. Restrictions on consulting deals. And no more pens with drug company names or other swag at conferences. These are part of a new ethics code that dozens of leading medical groups announced Wednesday, aimed at limiting the influence that drug and device makers have over patient care." MSNBC reports here.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment